
Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary “Real Life” Experience
Author(s) -
Serena Rupoli,
Alessandro Fiorentini,
Erika Morsia,
Gianluca SvegliatiBaroni,
Giorgia Micucci,
Luca Maroni,
Kimberly Blaine Garvey,
Alessandra Riva,
Lidia Da Lio,
Antonio Benedetti,
Massimo Offidani,
Attilio Olivieri,
Giuseppe Tarantino
Publication year - 2021
Publication title -
vascular health and risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.892
H-Index - 68
eISSN - 1178-2048
pISSN - 1176-6344
DOI - 10.2147/vhrm.s310615
Subject(s) - medicine , portal vein thrombosis , thrombosis , incidence (geometry) , cohort , cirrhosis , surgery , gastroenterology , optics , physics
Splanchnic vein thrombosis (SVT) is a potentially life-threatening complication of liver cirrhosis. This study aimed to evaluate the impact of a multi-disciplinary approach and early anticoagulation therapy (AT) on bleeding/thrombotic events, recanalization rates and outcome of cirrhotic patients with SVT.